WALTHAM, Mass., May 22, 2024 Repligen Corporation , a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the following June.
BNP Paribas Asset Management Holding S.A. reduced its holdings in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 4.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 330,848 shares of the biotechnology company’s stock after selling 14,538 shares during the […]
BNP Paribas Asset Management Holding S.A. trimmed its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 4.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 330,848 shares of the biotechnology company’s stock after selling 14,538 shares during the quarter. BNP Paribas Asset Management Holding S.A.’s holdings in Repligen were worth $59,486,000 as of […]
Here s Why Baron Discovery Fund Sold Repligen Corporation (RGEN) yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Pinnacle Wealth Planning Services Inc Acquires Shares of 1,127 Repligen Co (NASDAQ:RGEN) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.